Font Size: a A A
Keyword [No-reflow Phenomenon]
Result: 41 - 60 | Page: 3 of 4
41. Effect Of Anticoagulant And Antiplatelet Therapy Before The Intracavitary Therapy Of Lower Limb Atherosclerosis Occlusion On Clinical Outcomes
42. Effects Of Intracoronary Nitroprusside And Tirofiban Injection On The No-reflow Phenomenon During Percutaneous Coronary Intervention
43. The Effects Of Tirofeban Administrated At Various Time Points On No-reflow Phenomenon During Percutaneous Coronary Intervention
44. Inflammatory Factor Induces No-reflow Through Activation Of Cyclooxygenase Signaling Pathway
45. Meta-analysis Of The Efficacy And Safety Of Intracoronary Administration Of Tirofiban For No-reflow Phenomenon
46. Cardioprotective Effects Between SK&F96365 And LOE908 To Ischemia/ Reperfusion Injury In Vivo Rabbits
47. Application Of AngioJet Thrombus-aspirating Device In Patients With Acute ST Segment Elevation Myocardial Infarction And Thrombus-Rich Lesions
48. Analysis Of Risk Factors And Evaluation On Risk Prediction Of No-reflow Phenomenon In Patients Treated With Primary Percutaneous Coronary Intervention For ST-segment Elevation Myocardial Infarction
49. A Metabolomics Study Of Myocardial No-reflow Phenomenon And Limb Ischemia Per-conditioning
50. Research Of The Platelet-to-lymphocyte Ratio In Predicing No-reflow Phenomenon After Primary Percutaneous Coronary Intervention In Patients With Acute ST-segment Elevation Myocardial Infarction
51. Correlation Between Red Cell Distribution Width To Platelet Ratio And No-Reflow Phenomenon In Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
52. Impact Of Loading Ticagrelor On Coronary No Reflow During Emergency PCI In Patients With Acute ST Segment Elevation Myocardial Infarction
53. Observation Of No-reflow Phenomenon After Emergency PCI In STEMI Patients
54. Study On Risk Factors Of No-reflow In Emergency Percutaneous Coronary Intervention
55. Effect Of Prophylactic Use Of Nicorandil On No-reflow Phenomenon In Patients With Acute St-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
56. The Risk Factors Analysis Of No-reflow Phenomenon In Patients With STEMI Undergoing PCI
57. Risk Factors And Efficacy Of Nicorandil On No-reflow Phenomenon In Patients With Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention
58. Effect Of Preoperative Loading Dose Ticagrelor And Clopidogrel On No-reflow Phenomenon During Intervention In Patients With St-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention:a Systematic Review And Meta-analy
59. Effects Of Nicorandil On Myocardial Ischemia-reperfusion Vascular Endothelial Function In Rats
60. Clinical Study Of Fibrinolytic Enzyme Preconditioning In Delayed Coronary Intervention
  <<First  <Prev  Next>  Last>>  Jump to